Table 3 Bayesian Analysis of Change from Baseline SGRQ Score up to Month 6
Placebo | DNX 5 mg | DNX 10 mg | DNX 25 mg | DNX 35 mg | DNX 50 mg | |
|---|---|---|---|---|---|---|
N | 101 | 102 | 100 | 103 | 100 | 99 |
Baseline SGRQ Total Score | 46.21 (17.426) | 47.16 (16.057) | 45.97 (14.991) | 48.47 (17.514) | 47.18 (15.871) | 46.19 (16.669) |
n | 85 | 96 | 86 | 90 | 86 | 85 |
Mean Change from Baseline (90% CI) | −4.11 (−6.25,-2.00) | −3.44 (−5.51,-1.38) | −4.19 (−6.28,-2.12) | −4.94 (−7.03,-2.91) | −4.12 (−6.22,-1.99) | −3.41 (−5.55,-1.26) |
Mean Difference from Placebo (90% CI) | 0.68 (−2.26,3.67) | −0.08 (− 3.05,2.84) | −0.83 (− 3.81,2.09) | −0.01 (− 3.06,2.97) | 0.70 (−2.33,3.76) |